October 26, 2016
(The Wall Street Journal) – Many people are excited by the potential of the genetic tool Crispr-Cas9 to serve as a kind of molecular scissors to cut and repair malfunctioning DNA. The tool has generated hundreds of millions of dollars in investment, a tense patent battle and even a forthcoming Jennifer Lopez TV drama. But Cas9 isn’t the only possible application of Crispr. Dr. Barrangou, now a food scientist who runs a Crispr lab at North Carolina State, is among a growing number of researchers who think that other approaches may reach doctors and patients more quickly.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.